FDA approves new Alzheimer's treatment, donanemab from Eli Lilly - CBS News
- FDA approves new Alzheimer's treatment, donanemab from Eli Lilly CBS News
- Approval of Newest Alzheimer's Drug Will Accelerate New Era of Treatment The Wall Street Journal
- FDA Approves Second Alzheimer's Drug after Promising Trial The Daily Beast
- FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNN
- FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s The New York Times